Richard Sullivan, Co-Director of the Centre for Conflict and Health Research, and Professor of Cancer and Global Health at King’s College London, shared a post on X about a recent article he and his colleagues co-authored, adding:
“Report from the Pontifical Academy of Sciences and European Academy of Cancer Sciences meeting held in Vatican City.
A complex picture of innovation, global inequity and increasing divergence between science and systems implementation.”
Title: Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities
Authors: Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou-Zeid, Vanderlei Bagnato, Christian Brandts, Chien-Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking
Read the Full Article on Molecular Oncology
More posts featuring Richard Sullivan.